1. Home
  2. WST vs TECK Comparison

WST vs TECK Comparison

Compare WST & TECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TECK
  • Stock Information
  • Founded
  • WST 1923
  • TECK 1913
  • Country
  • WST United States
  • TECK Canada
  • Employees
  • WST N/A
  • TECK N/A
  • Industry
  • WST Medical/Dental Instruments
  • TECK
  • Sector
  • WST Health Care
  • TECK
  • Exchange
  • WST Nasdaq
  • TECK Nasdaq
  • Market Cap
  • WST 23.2B
  • TECK 24.9B
  • IPO Year
  • WST N/A
  • TECK N/A
  • Fundamental
  • Price
  • WST $332.77
  • TECK $41.18
  • Analyst Decision
  • WST Strong Buy
  • TECK Buy
  • Analyst Count
  • WST 5
  • TECK 7
  • Target Price
  • WST $437.75
  • TECK $64.86
  • AVG Volume (30 Days)
  • WST 494.1K
  • TECK 2.4M
  • Earning Date
  • WST 02-13-2025
  • TECK 02-19-2025
  • Dividend Yield
  • WST 0.25%
  • TECK 1.78%
  • EPS Growth
  • WST N/A
  • TECK N/A
  • EPS
  • WST 6.74
  • TECK 0.69
  • Revenue
  • WST $2,876,400,000.00
  • TECK $12,329,841,958.00
  • Revenue This Year
  • WST N/A
  • TECK N/A
  • Revenue Next Year
  • WST $6.08
  • TECK N/A
  • P/E Ratio
  • WST $49.37
  • TECK $58.17
  • Revenue Growth
  • WST N/A
  • TECK 114.29
  • 52 Week Low
  • WST $265.00
  • TECK $36.50
  • 52 Week High
  • WST $413.70
  • TECK $55.13
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.00
  • TECK 33.94
  • Support Level
  • WST $325.33
  • TECK $39.75
  • Resistance Level
  • WST $335.53
  • TECK $47.86
  • Average True Range (ATR)
  • WST 7.96
  • TECK 1.05
  • MACD
  • WST 0.32
  • TECK -0.34
  • Stochastic Oscillator
  • WST 78.28
  • TECK 17.63

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TECK Teck Resources Ltd

Teck is a base metals miner with copper and zinc operations in Canada, the United States, Chile, and Peru. After selling its metallurgical coal business, copper is now its major commodity by EBITDA contribution, followed by zinc. Teck is a top-three zinc miner. Its major new copper mine in Chile at the majority-owned Quebrada Blanca 2, in partnership with Sumitomo, will drive an increase in Teck's attributable copper production by roughly 75%. Along with a number of additional copper growth options, Teck's strategy is to rebalance its portfolio to low-carbon metals such as copper. It sold its oil sands business in early 2023 and its coal business in mid-2024.

Share on Social Networks: